Healthcare and Life Science
Latest H1 and Q2 2024 results for AstraZeneca
Pascal Soriot, Chief Executive Officer, AstraZeneca, commenting on the results said: “Building on our strong growth in the first half of the year and continued underlying demand for our medicines we are upgrading our FY 2024 guidance for both Total Revenue and Core EPS. ...
Trends, insights, data and case studies – UK-China Healthcare 2024
Such thought-provoking discussions on the healthcare sector in the UK and China, in 2024 and beyond, and the range of topics … from market overview to latest national security law, from market entry strategy to real case study! ...
Prism advise on sale of health screening software developers
Prism Corporate Broking are pleased to announce that our team have advised on the sale of health screening workflow software developers, Thomson Screening Solutions Ltd, to healthcare platform CCube Solutions which is backed by software-focused investors, Tern Capital. ...
Healx announces $47 million Series C financing and FDA clearance of phase 2 IND for Neurofibromatosis type 1 trial
Cambridge, UK – Healx, an AI-enabled, clinical-stage biotech company specialising in rare diseases, announced it has raised $47 million in a Series C round. ...
Pupils from The Galfrid School learn about DNA
Children at the primary school took part in an interactive morning learning DNA and genetics. ...
Empowering children and young people to become DNA heroes
D-CYPHR attended Leicester Grammar School STEM fair to highlight how every family can help childhood health research. Children and young people at the school have been involved in D-CYPHR for a while and it was a great chance to bring the project to life. ...
BioResource participant samples used in research discovering major cause of IBD
BioResource volunteers have contributed to new research from The Francis Crick Institute - in collaboration with UCL and Imperial College London - which discovered a new biological pathway as the principal driver of Inflammatory Bowel Disease (IBD) and related conditions, and which can ...
Ground-breaking study proves AI-driven programme has comparable effectiveness to human-delivered care while using up to 8 times fewer therapist hours
A new study by ieso Digital Health in collaboration with the and NIHR BioResource reveals that its AI-driven digital programme delivered results comparable to traditional human-led therapy for generalised anxiety. An estimated 1.2 million people in the UK are on waiting lists for NHS me...
Dylan shares his inspiring story on how all families can be part of research
Dylan reveals how he had major open heart surgery at just 7 years old. He joined the D-CYPHR programme and became a DNA hero to inspire others. ...
New genetic cause of obesity could help guide treatment
Researchers working with the NIHR BioResource discovered a genetic link between a specific blood group deficiency and obesity. The study identified a genetic variant affecting the SMIM1 gene, leading to higher body weight due to reduced energy expenditure at rest in Vel-negative individ...